BRIEF published on 11/05/2025 at 07:35, 29 days 23 hours ago ZEAL Reports Profitable Growth, Raises 2025 Forecast EBITDA Increase Customer Expansion Lottery Growth 2025 Forecast Dream House Raffle
PRESS RELEASE published on 11/05/2025 at 07:30, 29 days 23 hours ago ZEAL confirms profitable growth and raises forecast ZEAL Network SE experiences significant revenue growth and increases EBITDA by 55% in the first nine months of 2025. Lottery business drives revenue surge; games portfolio expansion contributes to growth Revenue Growth EBITDA Increase ZEAL Network SE Lottery Business Games Portfolio
BRIEF published on 10/29/2025 at 08:05, 1 month 6 days ago ZEAL Network SE Announces Earnings Call for 9M/2025 Results Investors Earnings Call ZEAL Network SE Quarterly Statement 2025 Financials
PRESS RELEASE published on 10/29/2025 at 08:00, 1 month 6 days ago Invitation to the Earnings Call of ZEAL Network SE - Publication of the Quarterly Statement 9M/2025 Invitation to the Earnings Call of ZEAL Network SE for the Quarterly Statement 9M/2025. Conference on 5th November 2025, 10:00 a.m. (CET). Register for the webcast Investors Webcast Earnings Call ZEAL Network SE Quarterly Statement
BRIEF published on 10/06/2025 at 09:05, 1 month 29 days ago ZEAL Network SE Shows Strong Q3 Performance Amidst Product Shifts Buy Recommendation ZEAL Network SE Q3 Financial Performance Eurojackpot Growth Lotto 6/49 Decline
PRESS RELEASE published on 10/06/2025 at 09:00, 1 month 29 days ago Original-Research: ZEAL Network SE (von NuWays AG): BUY Update: NuWays AG recommends BUY for ZEAL Network SE, with detailed analysis on Q3 lottery spending, indicating strong performance with Eurojackpot and decline in Lotto 6/49 demand NuWays AG Recommendation ZEAL Network SE EuroJackpot Q3 Lottery Spending
BRIEF published on 09/19/2025 at 09:05, 2 months 15 days ago ZEAL Network SE Increases FY'25 Guidance Amid Strong Demand ZEAL Network SE EuroJackpot Lottery Demand Traumhausverlosung FY'25 Guidance
PRESS RELEASE published on 09/19/2025 at 09:00, 2 months 15 days ago Original-Research: ZEAL Network SE (von NuWays AG): BUY Update on ZEAL Network SE's FY'25 guidance raise due to strong demand, including insight on lottery gross margin improvement. NuWays AG raises recommendation to BUY with a target price of EUR 65.00 Buy Recommendation NuWays AG ZEAL Network SE FY'25 Guidance Lottery Gross Margin
BRIEF published on 09/18/2025 at 19:36, 2 months 16 days ago ZEAL Network SE Adjusts Revenue Forecast for 2025 EBITDA Revenue Forecast Financial Guidance ZEAL Network SE Lottery Market
PRESS RELEASE published on 09/18/2025 at 19:31, 2 months 16 days ago EQS-Adhoc: ZEAL raises guidance ZEAL Network SE raises guidance for fiscal year 2025 due to improved lottery gross margin and positive Traumhausverlosung development Revenue Increase EBITDA Increase Guidance ZEAL Network SE Fiscal Year 2025
Published on 12/05/2025 at 02:35, 4 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 16 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 57 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
